Kashihara, Naoki
Nishio, Toshiki
Osonoi, Takeshi
Saka, Yosuke
Imasawa, Toshiyuki
Ohtake, Takayasu
Mizuno, Hiroshi
Shibagaki, Yugo
Kim, Hyosung
Yajima, Toshitaka
Sarai, Nobuaki http://orcid.org/0000-0002-7525-6102
Funding for this research was provided by:
AstraZeneca
Article History
Received: 29 April 2020
Accepted: 19 July 2020
First Online: 10 August 2020
Compliance with ethical standards
:
: N Kashihara has received consulting fees from AstraZeneca and has received research grants from AstraZeneca and the Japan Agency for Medical Research and Development. Y Saka, T Nishio, T Osonoi, T Imasawa, T Ohtake, H Mizuno, and Y Shibagaki have no conflicts of interest to disclose. H Kim, T Yajima, and N Sarai are employees of AstraZeneca K.K.
: All procedures performed in this study were approved by the institutional review board at each participating study site and were in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca’s data sharing policy described at ExternalRef removed.